Intravenous Immunoglobulin as Clinical Immune-Modulating Therapy

CMAJ - Canada
doi 10.1503/cmaj.130375
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Joule Inc.

Related search

High-Dose Intravenous Immunoglobulin Therapy in Multifocal Neuropathy

Neurology
Neurology
2011English

Intravenous Immunoglobulin Therapy for Resistant Ocular Behcet's Disease

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2001English

Aseptic Meningitis Associated With High Dose Intravenous Immunoglobulin Therapy.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1992English

High-Dose of Intravenous Immunoglobulin Modulates Immune Tolerance in Premature Infants

BMC Pediatrics
Child HealthPediatricsPerinatology
2018English

High-Dose Intravenous Immunoglobulin Therapy for Eosinophilic Granulomatosis With Polyangiitis

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Basic and Clinical Immunology – 3030. Subcutaneous Immunoglobulin Therapy: An Option for Patients Who Have Experienced Thrombotic Complications With Intravenous Therapy

World Allergy Organization Journal
ImmunologyPulmonaryAllergyRespiratory Medicine
2013English

Use of Intravenous Immunoglobulin Therapy in a Paediatric Rheumatology Service

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2008English

Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients With COVID-19: A Multicenter Retrospective Cohort Study

2020English

Central Retinal Venous Occlusion Following Intravenous Immunoglobulin Therapy-A Case Report

Journal of Medical Science And clinical Research
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy